Great Bay Bio (GBB), a Hong Kong-based biotech firm, is looking to raise $20-30 million in a fresh funding round, its chairman and co-founder Kingsley Leung told DealStreetAsia.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
